BackRAPT Therapeutics Overview

RAPT Therapeutics Research & Development

Research & Development expenses for RAPT.

Quarterly R&D Expenses

$12.03M
↓ 9.79% YoY

As of Sep 30, 2025

Annual R&D Expenses (TTM)

$82.87M
↓ 5.32% YoY

Trailing 12 months ending Sep 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin